Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06382077
Other study ID # CPSP5502
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date May 7, 2024
Est. completion date October 25, 2025

Study information

Verified date June 2024
Source Ondokuz Mayis University
Contact Burhan DOST, Assoc.Prof
Phone +903623121919
Email burhandost@hotmail.com
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The CPSP-Cardiac is a large, multi-center, observational study with the aim to investigate the incidence of chronic pain in the 3rd month postoperatively in cardiac surgery and its affecting factors.


Description:

Cardiovascular diseases pose a significant global health concern, particularly among the elderly population, leading to a surge in surgical interventions. Enhanced Recovery After Surgery (ERASĀ®) protocols, specifically ERASĀ® Cardiac, target improved perioperative pain management to optimize patient outcomes. Effective pain control aims to alleviate acute discomfort, prevent chronic pain development, facilitate early mobilization, reduce hospital stays, and enhance patient satisfaction and functional recovery. While pain intensity peaks within the initial days following cardiac surgery and gradually subsides, inadequate acute pain management can predispose patients to chronic pain, impairing their quality of life. Multimodal opioid-sparing analgesia strategies are recommended, with recent advancements in ultrasound-guided regional anesthesia techniques showing promise in enhancing acute pain relief and reducing opioid consumption, particularly through truncal fascial plane blocks and parasternal blocks. However, the impact of these techniques on chronic postsurgical pain remains incompletely understood. This multicenter study aims to investigate the incidence of chronic postsurgical pain following cardiac surgery, exploring the influence of various factors and their implications on patients' quality of life.


Recruitment information / eligibility

Status Recruiting
Enrollment 1176
Est. completion date October 25, 2025
Est. primary completion date May 7, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - patients will be undergoing a first-time cardiac surgery involving a median sternotomy, including coronary artery bypass grafting (CABG) and all open-heart procedures, such as valvular repairs/replacement. - patients between the ages of 18-80 years - American Society of Anesthesiologists (ASA) Physical Status score of II-III - patients will also sign the written informed consent form Exclusion Criteria: - patients scheduled for minimally invasive cardiac surgery, - patients with BMI>40, - patients who undergone thoracotomy, - patients with alcohol and drug addiction, - patients with severe dysfunction in a significant organ (e.g., presence of severe hepatic and renal disease), - patients who undergone emergency and redo surgeries, - patients who cannot be extubated within the first 8 hours postoperatively, - patients have a severe psychiatric diseases such as psychosis or dementia that restrict cooperation with the patient (patients who cannot evaluate verbal numerical pain scales), - patients who are pregnant and breastfeeding, - patients who cannot be reached by phone during the postoperative follow-up periods - patients who cannot communicate in the native language.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Turkey Baskent University Adana
Turkey Adiyaman Üniversitesi Adiyaman
Turkey Ankara University Ankara
Turkey Bilkent City Hospital Ankara
Turkey Hacettepe Üniversitesi Ankara
Turkey Akdeniz University Antalya
Turkey Antalya Eah Antalya
Turkey Bursa City Hospital Bursa
Turkey Bursa Yuksek Ihtisas Eah Bursa
Turkey Uludag Üniversitesi Bursa
Turkey Canakkale University Çanakkale
Turkey Hitit University Çorum
Turkey Denizli Dh Denizli
Turkey Düzce Üniversitesi Düzce
Turkey Ataturk University Erzurum
Turkey Sanko Üniversitesi Gaziantep
Turkey Medipol Mega Hospital I?stanbul
Turkey Süleyman Demirel Üniversitesi Isparta
Turkey Acibadem Atasehir Hospital Istanbul
Turkey Basahsehir Cam and Sakura Hospital Istanbul
Turkey Cemil Tasçioglu Sehir Hastanesi Istanbul
Turkey Istanbul University Istanbul
Turkey Kartal Kosuyolu Eah Istanbul
Turkey Koç University Hospital Istanbul
Turkey Marmara University Istanbul
Turkey Kocaeli Sehir Hastanesi Kocaeli
Turkey Kocaeli University Kocaeli
Turkey Mersin University Mersin
Turkey Mugla Eah Mugla
Turkey Recep Tayyip Erdogan Üniversitesi Rize
Turkey Burhan Dost Samsun
Turkey Ondokuz Mayis University Samsun Atakum
Turkey Samsun University Samsun
Turkey Sanliurfa Eah Sanliurfa
Turkey Karadeniz Teknik University Trabzon
Turkey Trabzon Ahi Avran Eah Trabzon

Sponsors (1)

Lead Sponsor Collaborator
Ondokuz Mayis University

Country where clinical trial is conducted

Turkey, 

References & Publications (3)

Dost B, De Cassai A, Balzani E, Tulgar S, Ahiskalioglu A. Effects of ultrasound-guided regional anesthesia in cardiac surgery: a systematic review and network meta-analysis. BMC Anesthesiol. 2022 Dec 29;22(1):409. doi: 10.1186/s12871-022-01952-7. — View Citation

Maessen T, Korir N, Van de Velde M, Kennes J, Pogatzki-Zahn E, Joshi GP; PROSPECT Working Group of the European Society of Regional Anaesthesia and Pain Therapy. Pain management after cardiac surgery via median sternotomy: A systematic review with procedure-specific postoperative pain management (PROSPECT) recommendations. Eur J Anaesthesiol. 2023 Oct 1;40(10):758-768. doi: 10.1097/EJA.0000000000001881. Epub 2023 Jul 19. — View Citation

Xiao MZX, Khan JS, Dana E, Rao V, Djaiani G, Richebe P, Katz J, Wong D, Clarke H. Prevalence and Risk Factors for Chronic Postsurgical Pain after Cardiac Surgery: A Single-center Prospective Cohort Study. Anesthesiology. 2023 Sep 1;139(3):309-320. doi: 10.1097/ALN.0000000000004621. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary The incidence of chronic postsurgical pain The incidence of chronic postsurgical pain (CPSP) in the third month following cardiac surgery along with identifying the factors that influence it. CPSP as pain that (A) emerges after surgery, (B) is distinct from pre-procedural pain, (C) is not caused by other factors, and (D) persists for at least three months. Postoperative 3rd and 6th months
Secondary Postoperative opioid consumption in the first 24 hours Morphine consumption in the first 24 hours will be measured. Postoperative day 1
Secondary Postoperative pain scores Pain at rest and during activity (coughing and deep breathing) will be assessed by numerical rating scale (NRS) scores at 0, 3, 6, 12, and 24 hours after extubation. The NRS is an 11-point numeric scale that ranges from 0 to 10. The NRS is an 11-point scale consisting of integers from 0 to 10: 0 indicates "no pain" and 10 indicates "the worst pain ever possible." Postoperative day 1
Secondary The incidences of postoperative nausea and vomiting The severity of postoperative nausea and vomiting (PONV) will be assessed using a descriptive verbal rating scale at 0, 3, 6, 12, and 24 hours after extubation. The PONV scale is 0 = none, 1 = mild nausea, 2 = moderate nausea, 3 = vomiting once, and 4 = vomiting more than once Postoperative day 1
Secondary The number of patients with side effects and complications The number of patients have any side effects and complications will be recorded. The time from surgery to the time of discharge to the home; an average of 14 days
Secondary Time to extubation After the operation, the time until the patient is extubated will be recorded. Postoperative Day 1
Secondary Length of stay in the intensive care unit Total duration of stay in intensive care unit (ICU) will be recorded The time from admission to the ICU to the time of discharge to the hospital ward; during the hospital stay, an average of 7 days
Secondary Length of stay in the hospital Their stay in the hospital will be recorded. Measured in days admitted in the hospital, an average of 14 days
Secondary Chronic pain status at 3 and 6 months After discharge, patients will be contacted at 3 and 6 months. Pain intensity and status will be assessed using the Brief Pain Inventory-Short Form, and the character of pain will be evaluated using the Leeds Assessment of Neuropathic Signs and Symptoms Pain Questionnaire score. 90 and 180 days after surgery
Secondary Psychological assessment The patient's anxiety and depression status will be assessed using the Hospital Anxiety and Depression Scale. 90 and 180 days after surgery
Secondary Quality of life assessment Pain Self-Efficacy Questionnaire will be used to assess the influence of chronic pain on the individual's daily life. 90 and 180 days after surgery
Secondary Postoperative complications at 3 and 6 months The severity of complications will be evaluated using the 'Clavien-Dindo' classification. Additionally, the 'Comprehensive Complication Index' (https://www.cci-calculator.com/cciCalculator) will be used to evaluate the patient's overall postoperative morbidity. 90 and 180 days after surgery
See also
  Status Clinical Trial Phase
Recruiting NCT05920382 - Radiofrequency Ablation for the Treatment of Post-knee Arthroplasty Chronic Pain. N/A
Completed NCT04814992 - Pre-op Cognitive Behavior Therapy to Decrease Chronic Post-Surgical Pain in TKA N/A
Completed NCT02240199 - Perioperative Pregabalin and Lidocaine to Reduce Chronic Breast Cancer Pain Phase 3
Active, not recruiting NCT06392919 - The Impact of Repetitive Transcranial Magnetic Stimulation on the Prognosis of Elderly Surgical Patients N/A
Recruiting NCT03525938 - Transversus Abdominis Plane Block for Chronic Postsurgical Orchalgia N/A
Active, not recruiting NCT04681183 - Pilot Study Evaluating Neuro-Imaging Correlates of Epigenetic Finding in Prediction of Chronic Postsurgical Pain
Recruiting NCT05304286 - Psychophysical and Neural Mechanisms Contributing to Chronic Post-Surgical Pain in Adolescents and Adults N/A
Not yet recruiting NCT06344169 - Dinalbuphine Ester (Naldebain) for Pain Management After Cesarean Section Phase 2/Phase 3